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Fukuyama type congenital muscular
dystrophy (FCMD) is an autosomal
recessive disorder that is observed
predominantly in Japanese
populations [1]. Recently, the cause
of this syndrome was discovered to
be lesions in the gene encoding the
protein fukutin; these lesions involve
retroposon insertion and point
mutations, which result in a
truncated protein [2]. Consistent
with the phenotypic patterns of the
disease, the fukutin mRNA has been
found in skeletal muscles, heart,
brain and pancreas [2]. Fukutin
contains a signal peptide and is
localized to the Golgi and secretory
granules [2]. Here, we report on a
detailed computer analysis of the
fukutin protein sequence, resulting
in the prediction that it is an enzyme
that modifies cell-surface
glycoproteins or glycolipids. 
A gapped BLASTP [3] search of
the non-redundant (NR) database at
the National Center for
Biotechnology Information using the
fukutin sequence as the query
revealed significant hits (with e-
values < 10–9) not only to
Caenorhabditis elegans proteins, such
as T07D3.4 and T07A5.1, but also to
the uncharacterized protein RP688
from the intracellular parasitic
bacterium Rickettsia prowazekii
(e < 10–4). The RP688 sequence was
used for further analysis of this
protein family by iteratively
searching the NR database using the
PSI-BLAST program, which was run
with the cut-off of e = 0.001 [3]. At
convergence, not only fukutin and
its C. elegans homologs, but also
bacterial proteins involved in
polysaccharide/phosphorylcholine
modification and a yeast protein
involved in mannosyl
phosphorylation of oligosaccharides
were retrieved from the database.
Reverse searches with these
sequences retrieved the original
members of the fukutin family
without any false positives. Fukutin,
therefore, belongs to a family of
proteins associated with the
modification of the cell surface. 
A multiple alignment of the
fukutin protein family was
constructed using Gibbs sampling, as
implemented in PROBE [4], in
conjunction with the –m4 option of
PSI-BLAST (Figure 1). The
alignment shows prominent
conservation in an amino-terminal
block, followed by a weakly
conserved carboxy-terminal region.
The most notable feature of the
amino-terminal region is the presence
of the strictly conserved signature
G[TS]hhGhhx4hhxaxxDxD (in
single-letter amino acid code and in
which ‘h’ is a hydrophobic amino
acid, ‘a’ is an aromatic amino acid
and ‘x’ denotes any amino acid). A
pattern search with this motif
recovers from the NR database the
fukutin family in its entirety
without any false positives. The
carboxy-terminal region contains a
motif with a conserved aspartate
residue flanked by hydrophobic
residues (Figure 1). Secondary
structure prediction using the PHD
program [5] suggests a compact α/β
fold for the fukutin domain
(Figure 1).
LicD2 from Streptococcus
pneumoniae is involved in the addition
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LALLDYIDETCKKHDIPYFLSYGTMLGAIRHKGMIPWDDDIDISLYREDYERLLKIIEEENHPRYKVLSYDTSSWYFHNFASI-LDTSTVIEDHVKY---------KRHDTSLFIDVFPIDRFTDLS------------IVDKSYKYV
LEILDYIDTLCKKHNINYIINYGTLIGAVRHEGFIPWDDDIDLSMPREDYQRFINIFQKEKS-KYKLLSLETDKNYFNNFIKI-TDSTTKIIDTRNT---------KTYESGIFIDIFPIDRFDD-PKVIDTCYKL-ESFKLLSFSKH
MDAIKEFQKICKENNIDFFLRGGSVLGAVKYDGFIPWDDDMDIAVPREGYDK----LPGIFKDRIIAGKYQVLAYQYCDTLHCYFPRLFLLEDERKRLG----LPRNTNLGLHLIDIIPLDGAPNHS----FLRKL---YFGKVYWYR
LNILDYFHALCERHQIHYSLGGGTLIGAIRHKGFIPWDDDIDVYMHRDEYQRFVDVWFQETHEYYNIETVEDILAQK-------TGEMAKIFDCRTQI-----TEIAGKKSAMFIDIFIYDGVPNDPKIIC--------SFMKKYRRT
YQLMKDTHELLTKNNIKYWIESGTLLGAVRHQGIIPFDDDLDIGIMHEDEIH-----LQQILPQFEQLGYRVKHNKIY------VICGERCLDIFLFH------KEKDKFIHVIYDKYPNDFFYDHEL-----------YPLKKYKFG
KENLSLLKRICNKYNLDFILFFGTLLGAVREHDFISHDEDIDIVMPISDLER------------FKDILFILRE----------NGFEVARFERRGFM--------SIIRNGEYIDIYFFTPYAEDRRLSTCICE----LCEVKYINN
NSLIRNFQKFVKANGLISWLSHGTLYGYLYDGLKFPWDVDHDLQMPIKHLHY--------LSQYFNQSLILEDPR---------EGNGRFLLDVGSAITVGVHGNGENNIDARFIDIDSGIYIDITGLSVSSDAAK---QYMSKFVEE
NSMIRTFQKFTKANGIISWLSHGTLYGYLYNGMAFPWDNDFDLQMPIKHLQL--------LSQYFNQSLILEDPR---------QGNGRYFLDVSDSLTVRINGNGKNNIDARFIDVDTGLYIDITGLASTSAPSR---DYLNSYIEE
VEELAQLRDELIEFDMYPFLNGGTFLGWYRECSIIPHTTDMDLSVFAKDYNP---IYVELLHSYWNPSSFEV------------WRMLGMVEDSFEI------TIQTKKWFEYPIDLFLMYEGIENGKLTHHWVGGIA-TDGTKYKFT
AEKLAEFRDVLLTFNMFAFLNGGTLLGWYRECGFIPHTADIDLAMFAEDFHP--------EITHFLLSRTSSFQL---------LRSLGMLNDSYEL------TVTPKTGYIVNMDLFLMYKDVHKNGSVINWVGG----AKSRFCRS
KELLQLAAKTLNKLGVPFWLSSGTCLGWYRQCNIIPYSKDVDLGIFIQDYKS-------DIILAFQDAGLPL------------KHKFGKVEDSLELS--------FQGKDDVKLDVFFFYEETD-----HMWNGGTQAKTGKKFKYL
.p.l..hpp.h.p.sh..hl..GThlGhh+ppshIPas.DhDl.h..pchp.............a....h....................hbD.....................hDlh......p..................pa.b.
A multiple alignment of fukutin family proteins.
The proteins designations include: gene
name_species abbreviation_GenBank
identification number. The CpsG protein is
encoded by the operon involved in capsular
polysaccharide biosynthesis in S.
pneumoniae. The species abbreviations are
as follows: Spn, S. pneumoniae; Rp,
Rickettsia prowazekii; Pi, Prevotella
intermedia; Hi, H. influenzae; Sc,
Saccharomyces cerevisiae; Ce, C. elegans;
and Hs, Homo sapiens. The alignment is
colored according to the 90% consensus
with the following consensus terms: p
(RKHEDNQST), polar; b (FLIMYWKREQ),
big; s (STCVNDPGAS), small; h
(LIVMFWYAC), hydrophobic; l (LVIMA),
aliphatic; c (RKHED), charged; G,A or S,
tiny; a (FYWH), aromatic; + (RKH), positive;
S or T, alcohol. The coloring scheme used is:
grey, charged; green, small; blue,
hydrophobic/ aromatic; pink, tiny; yellow,
alcohol; purple, polar; orange, big. Protein
secondary structure was predicted using the
PHD program [4], with the multiple alignment
as the query, and is shown above the
alignment (H indicates α helix and e indicates
β strand). 
of phosphorylcholine residues to
lipoteichoic acid, an important
component of the cell 
wall in Gram-positive bacteria [6]. It
has been proposed that LicD2 is an
enzyme that catalyzes the transfer of
phosphorylcholine to its teichoic
acid substrates from a CDP-choline
donor [6]. Similarly, the Haemophilus
influenzae homolog — LicD is
required for the addition of
phosphorylcholine to the Gram-
negative bacterial lipopolysaccharide
[7]. The yeast protein MNN4
participates in a similar reaction in
which a mannosyl phosphate residue
is added from a GDP–mannose
donor to both N-linked and O-
linked oligosaccharides on proteins
([8] and references therein). These
studies, taken together with the
sequence conservation pattern,
suggest that the fukutin family
proteins are phosphoryl-ligand
transferases. The presence of the
DxD motif and a distal aspartate
residue that is conserved in most of
the sequences suggests that these
enzymes coordinate a divalent
cation, which is similar to a number
of nucleotidyltransferases (for
example, see [9]).
Drawing from knowledge of the
functions of these proteins and the
subcellular localization of fukutin,
we predict that this protein modifies
cell-surface molecules, most
probably through the attachment of
phosphoryl-sugar moieties. The
brains of individuals with FCMD
show an abnormal pattern of
gangliosides [10], which suggests
that the transferase activity of
fukutin could participate in one of
the many steps of glycolipid
modifications. Glycolipid
modifications are an important
factor in determining the adhesive
properties of cells [11]. Thus,
fukutin might regulate neural
migration and muscle organization
by affecting the biogenesis of crucial
adhesion molecules. In this regard,
it might be of interest that
disruption of the basement
membrane, linked to an M-laminin
deficiency, has been reported in
FCMD patients [12]. All the
bacterial homologs of fukutin are
from pathogenic bacteria and
experimental evidence from H.
influenzae [7] and S. pneumoniae [6]
shows that the surface modifications
catalyzed by these proteins (LicD
and LicD2, respectively) are
necessary for the adhesion of the
bacteria to mammalian lung cells
and pathogenesis. The sequence
conservation described here,
together with the apparent absence
of fukutin family members in non-
pathogenic bacteria, might suggest
that the genes coding for these
proteins have been horizontally
transferred from eukaryotes to the
pathogenic bacteria. A member of
the fukutin family was detected in
an expressed sequence tag from
Trypanosoma brucei (AI077222),
which suggests a possible role for
this protein in the surface
modifications of this eukaryotic
pathogen (data not shown).
The proposed function and the
phylogenetic distribution of the
fukutin family members resemble
those of the glycosyl transferases of
the Fringe family that are involved in
the modification of surface molecules
of the Notch pathway in
development [13]. Like the fukutin
family proteins, Fringe homologs are
seen in pathogenic but not in free-
living bacteria. Thus horizontal gene
transfer from eukaryotes might be a
common theme in the origin of the
enzymes involved in surface
modification in bacterial pathogens,
resulting in similarities in adhesion
mechanisms between these bacteria
and eukaryotic cells.
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